Literature DB >> 22689879

HIV-1 infection of human intestinal lamina propria CD4+ T cells in vitro is enhanced by exposure to commensal Escherichia coli.

Stephanie M Dillon1, Jennifer A Manuzak, Amanda K Leone, Eric J Lee, Lisa M Rogers, Martin D McCarter, Cara C Wilson.   

Abstract

Microbial translocation has been linked to systemic immune activation in HIV-1 disease, yet mechanisms by which microbes may contribute to HIV-associated intestinal pathogenesis are poorly understood. Importantly, our understanding of the impact of translocating commensal intestinal bacteria on mucosal-associated T cell responses in the context of ongoing viral replication that occurs early in HIV-1 infection is limited. We previously identified commensal Escherichia coli-reactive Th1 and Th17 cells in normal human intestinal lamina propria (LP). In this article, we established an ex vivo assay to investigate the interactions between Th cell subsets in primary human LP mononuclear cells (LPMCs), commensal E. coli, and CCR5-tropic HIV-1(Bal). Addition of heat-killed E. coli to HIV-1-exposed LPMCs resulted in increases in HIV-1 replication, CD4 T cell activation and infection, and IL-17 and IFN-γ production. Conversely, purified LPS derived from commensal E. coli did not enhance CD4 T cell infection. E. coli exposure induced greater proliferation of LPMC Th17 than Th1 cells. Th17 cells were more permissive to infection than Th1 cells in HIV-1-exposed LPMC cultures, and Th17 cell infection frequencies significantly increased in the presence of E. coli. The E. coli-associated enhancement of infection was dependent on the presence of CD11c(+) LP dendritic cells and, in part, on MHC class II-restricted Ag presentation. These results highlight a potential role for translocating microbes in impacting mucosal HIV-1 pathogenesis during early infection by increasing HIV-1 replication and infection of intestinal Th1 and Th17 cells.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22689879      PMCID: PMC3395168          DOI: 10.4049/jimmunol.1200681

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  59 in total

1.  Dynamics of CCR5 expression by CD4(+) T cells in lymphoid tissues during simian immunodeficiency virus infection.

Authors:  R S Veazey; K G Mansfield; I C Tham; A C Carville; D E Shvetz; A E Forand; A A Lackner
Journal:  J Virol       Date:  2000-12       Impact factor: 5.103

2.  Enhanced levels of functional HIV-1 co-receptors on human mucosal T cells demonstrated using intestinal biopsy tissue.

Authors:  P A Anton; J Elliott; M A Poles; I M McGowan; J Matud; L E Hultin; K Grovit-Ferbas; C R Mackay; J V Giorgi
Journal:  AIDS       Date:  2000-08-18       Impact factor: 4.177

3.  Identifying the target cell in primary simian immunodeficiency virus (SIV) infection: highly activated memory CD4(+) T cells are rapidly eliminated in early SIV infection in vivo.

Authors:  R S Veazey; I C Tham; K G Mansfield; M DeMaria; A E Forand; D E Shvetz; L V Chalifoux; P K Sehgal; A A Lackner
Journal:  J Virol       Date:  2000-01       Impact factor: 5.103

4.  Long-term non-progressors display a greater number of Th17 cells than HIV-infected typical progressors.

Authors:  María Salgado; Norma I Rallón; Berta Rodés; Mariola López; Vincent Soriano; José Miguel Benito
Journal:  Clin Immunol       Date:  2011-03-02       Impact factor: 3.969

5.  HIV persistence in the gut mucosa of HIV-infected subjects undergoing antiretroviral therapy correlates with immune activation and increased levels of LPS.

Authors:  Gabriella d'Ettorre; Mirko Paiardini; Lorenzo Zaffiri; Mauro Andreotti; Giancarlo Ceccarelli; Cecilia Rizza; Marileda Indinnimeo; Stefano Vella; Claudio M Mastroianni; Guido Silvestri; Vincenzo Vullo
Journal:  Curr HIV Res       Date:  2011-04       Impact factor: 1.581

6.  Plasma levels of soluble CD14 independently predict mortality in HIV infection.

Authors:  Netanya G Sandler; Handan Wand; Annelys Roque; Matthew Law; Martha C Nason; Daniel E Nixon; Court Pedersen; Kiat Ruxrungtham; Sharon R Lewin; Sean Emery; James D Neaton; Jason M Brenchley; Steven G Deeks; Irini Sereti; Daniel C Douek
Journal:  J Infect Dis       Date:  2011-01-20       Impact factor: 5.226

Review 7.  Endotoxin, toll-like receptor 4, and the afferent limb of innate immunity.

Authors:  B Beutler
Journal:  Curr Opin Microbiol       Date:  2000-02       Impact factor: 7.934

8.  A preponderance of CCR5(+) CXCR4(+) mononuclear cells enhances gastrointestinal mucosal susceptibility to human immunodeficiency virus type 1 infection.

Authors:  M A Poles; J Elliott; P Taing; P A Anton; I S Chen
Journal:  J Virol       Date:  2001-09       Impact factor: 5.103

9.  Fate mapping of IL-17-producing T cells in inflammatory responses.

Authors:  Keiji Hirota; João H Duarte; Marc Veldhoen; Eve Hornsby; Ying Li; Daniel J Cua; Helena Ahlfors; Christoph Wilhelm; Mauro Tolaini; Ursula Menzel; Anna Garefalaki; Alexandre J Potocnik; Brigitta Stockinger
Journal:  Nat Immunol       Date:  2011-01-30       Impact factor: 25.606

10.  CD4+ T cell depletion during all stages of HIV disease occurs predominantly in the gastrointestinal tract.

Authors:  Jason M Brenchley; Timothy W Schacker; Laura E Ruff; David A Price; Jodie H Taylor; Gregory J Beilman; Phuong L Nguyen; Alexander Khoruts; Matthew Larson; Ashley T Haase; Daniel C Douek
Journal:  J Exp Med       Date:  2004-09-13       Impact factor: 14.307

View more
  35 in total

Review 1.  Interaction between endogenous bacterial flora and latent HIV infection.

Authors:  Ann Florence B Victoriano; Kenichi Imai; Takashi Okamoto
Journal:  Clin Vaccine Immunol       Date:  2013-04-24

2.  Low abundance of colonic butyrate-producing bacteria in HIV infection is associated with microbial translocation and immune activation.

Authors:  Stephanie M Dillon; Jon Kibbie; Eric J Lee; Kejun Guo; Mario L Santiago; Gregory L Austin; Sara Gianella; Alan L Landay; Andrew M Donovan; Daniel N Frank; Martin D McCARTER; Cara C Wilson
Journal:  AIDS       Date:  2017-02-20       Impact factor: 4.177

3.  Brief Report: Inflammatory Colonic Innate Lymphoid Cells Are Increased During Untreated HIV-1 Infection and Associated With Markers of Gut Dysbiosis and Mucosal Immune Activation.

Authors:  Stephanie M Dillon; Moriah J Castleman; Daniel N Frank; Gregory L Austin; Sara Gianella; Andrew C Cogswell; Alan L Landay; Edward Barker; Cara C Wilson
Journal:  J Acquir Immune Defic Syndr       Date:  2017-12-01       Impact factor: 3.731

4.  The natural killer cell interferon-gamma response to bacteria is diminished in untreated HIV-1 infection and defects persist despite viral suppression.

Authors:  Stephanie M Dillon; Eric J Lee; Julia M Bramante; Edward Barker; Cara C Wilson
Journal:  J Acquir Immune Defic Syndr       Date:  2014-03-01       Impact factor: 3.731

Review 5.  The gut microbiome and HIV-1 pathogenesis: a two-way street.

Authors:  Stephanie M Dillon; Daniel N Frank; Cara C Wilson
Journal:  AIDS       Date:  2016-11-28       Impact factor: 4.177

6.  A compartmentalized type I interferon response in the gut during chronic HIV-1 infection is associated with immunopathogenesis.

Authors:  Stephanie M Dillon; Kejun Guo; Gregory L Austin; Sara Gianella; Phillip A Engen; Ece A Mutlu; John Losurdo; Garth Swanson; Prachi Chakradeo; Ali Keshavarzian; Alan L Landay; Mario L Santiago; Cara C Wilson
Journal:  AIDS       Date:  2018-07-31       Impact factor: 4.177

7.  Interferon Alpha Subtype-Specific Suppression of HIV-1 Infection In Vivo.

Authors:  Kerry J Lavender; Kathrin Gibbert; Karin E Peterson; Erik Van Dis; Sandra Francois; Tyson Woods; Ronald J Messer; Ali Gawanbacht; Janis A Müller; Jan Münch; Katie Phillips; Brent Race; Michael S Harper; Kejun Guo; Eric J Lee; Mirko Trilling; Hartmut Hengel; Jacob Piehler; Jens Verheyen; Cara C Wilson; Mario L Santiago; Kim J Hasenkrug; Ulf Dittmer
Journal:  J Virol       Date:  2016-06-10       Impact factor: 5.103

Review 8.  Complexities of Gut Microbiome Dysbiosis in the Context of HIV Infection and Antiretroviral Therapy.

Authors:  S X Li; Ajs Armstrong; C P Neff; M Shaffer; C A Lozupone; B E Palmer
Journal:  Clin Pharmacol Ther       Date:  2016-04-16       Impact factor: 6.875

9.  Alterations in the gut microbiota associated with HIV-1 infection.

Authors:  Catherine A Lozupone; Marcella Li; Thomas B Campbell; Sonia C Flores; Derek Linderman; Matthew J Gebert; Rob Knight; Andrew P Fontenot; Brent E Palmer
Journal:  Cell Host Microbe       Date:  2013-09-11       Impact factor: 21.023

Review 10.  Microbial translocation and microbiome dysbiosis in HIV-associated immune activation.

Authors:  Alexander S Zevin; Lyle McKinnon; Adam Burgener; Nichole R Klatt
Journal:  Curr Opin HIV AIDS       Date:  2016-03       Impact factor: 4.283

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.